NFGH
BEAM icon

Nan Fung Group Holdings’s Beam Therapeutics BEAM Stock Holding History

Nan Fung Group Holdings’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54,903
Closed -$3.15M – 42
2022
Q1 		$3.15M Hold
54,903
– – 1.49% 12
2021
Q4 		$4.38M Hold
54,903
– – 1.29% 13
2021
Q3 		$4.78M Buy
54,903
+6,243
+13% +$627K 1.53% 11
2021
Q2 		$6.26M Buy
+48,660
New +$3.88M 1.95% 6

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Nan Fung Group Holdings's BEAM Position: Q2 2022 in Review

Nan Fung Group Holdings sold out of Beam Therapeutics (BEAM) in Q2 2022, closing a stake of 54,903 shares — an estimated $3.15M sold.

Nan Fung Group Holdings first reported a position in BEAM in Q2 2021 and held it in 4 quarters. The position peaked at $6.26M in Q2 2021. 205 funds tracked by Wall St. Rank hold BEAM as of Q2 2022.

  • Nan Fung Group Holdings reported no remaining Beam Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 54,903 Beam Therapeutics shares in Q2 2022, an estimated $3.15M.
  • Nan Fung Group Holdings first reported a position in Beam Therapeutics in Q2 2021 and held it in 4 quarters.
  • Nan Fung Group Holdings's Beam Therapeutics position peaked at $6.26M in Q2 2021.
  • 205 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2022.

Based on Nan Fung Group Holdings's 13F filing for Q2 2022, filed 12 Aug 2022.